Sarah J. Pirrie
Birmingham, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Erratum: Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 23, 2025
SMALL: open surgery versus minimally invasive vacuum-assisted excision for small screen-detected breast cancer-protocol for a phase III randomised multicentre trial.
Journal: BMJ open
Published: April 09, 2025
Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 14, 2025
Image directed redesign of bladder cancer treatment pathways: the BladderPath RCT.
Journal: Health technology assessment (Winchester, England)
Published: September 09, 2024
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial.
Journal: The Lancet. Rheumatology
Published: November 16, 2023
Selenium and Vitamin E for Prevention of Non-Muscle-Invasive Bladder Cancer Recurrence and Progression: A Randomized Clinical Trial.
Journal: JAMA network open
Published: October 17, 2023
Boosting and broadening recruitment to UK cancer trials: towards a blueprint for action.
Journal: BMJ oncology
Published: May 25, 2023
Correlative studies of the Breast Cancer Index (HOXB13/IL17BR) and ER, PR, AR, AR/ER ratio and Ki67 for prediction of extended endocrine therapy benefit: a Trans-aTTom study.
Journal: Breast cancer research : BCR
Published: August 24, 2022
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease.
Journal: Nature medicine
Published: August 05, 2022
TUXEDO: A phase I/II trial of cetuximab with chemoradiotherapy in muscle-invasive bladder cancer.
Journal: BJU international
Published: July 31, 2022
Visualising harms in publications of randomised controlled trials: consensus and recommendations.
Journal: BMJ (Clinical research ed.)
Published: May 16, 2022
Last Updated: 09/26/2026